0.6000
+0.0200
+(3.45%)
As of 11:04:07 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
105.0640
749.5360
1,378.1260
3,117.6770
396.3170
Cost of Revenue
141.7930
723.7870
1,517.5270
2,249.6040
510.2290
Gross Profit
-36.7290
25.7490
-139.4010
868.0730
-113.9120
Operating Expense
8,606.5490
5,853.2770
5,752.6960
12,849.2240
10,054.6990
Operating Income
-8,643.2780
-5,827.5280
-5,892.0970
-11,981.1510
-10,168.6110
Net Non Operating Interest Income Expense
-1,289.2870
-1,041.4860
-347.9300
-799.9120
-84.4380
Other Income Expense
-718.9590
-674.8530
275.8390
-86,164.8870
-3,991.7830
Pretax Income
-10,651.5240
-7,543.8670
-5,964.1880
-98,945.9500
-14,244.8320
Net Income Common Stockholders
-15,263.7540
-12,127.9930
-16,854.5180
-98,877.1710
-14,244.8320
Diluted NI Available to Com Stockholders
-15,263.7540
-12,127.9930
-16,854.5180
-98,877.1710
-14,244.8320
Basic EPS
-17.67
-20.99
-30.17
-118.00
-38.00
Diluted EPS
-17.67
-20.99
-30.17
-118.00
-38.00
Basic Average Shares
3,673.7840
577.8660
558.7180
834.5680
377.2450
Diluted Average Shares
3,673.7840
577.8660
558.7180
834.5680
377.2450
Rent Expense Supplemental
97.2720
68.0000
1.7500
21.0000
57.7880
Total Expenses
8,748.3420
6,577.0640
7,270.2230
15,098.8280
10,564.9280
Net Income from Continuing & Discontinued Operation
-15,263.7540
-12,127.9930
-16,854.5180
-98,877.1710
-14,244.8320
Normalized Income
-9,505.9930
-6,506.9050
-6,113.0660
-12,712.2840
-10,253.0490
Interest Expense
0.0870
27.7120
53.0570
44.3830
35.0530
Net Interest Income
-1,289.2870
-1,041.4860
-347.9300
-799.9120
-84.4380
EBIT
-10,651.4370
-7,516.1550
-5,911.1310
-98,901.5670
-14,209.7790
EBITDA
-10,053.6630
-6,852.6650
-5,163.0970
-96,438.9770
-12,749.2670
Reconciled Cost of Revenue
141.7930
723.7870
1,517.5270
2,249.6040
510.2290
Reconciled Depreciation
597.7740
663.4900
748.0340
2,462.5900
1,460.5120
Net Income from Continuing Operation Net Minority Interest
-10,311.6710
-7,127.1440
-5,837.2270
-98,877.1710
-14,244.8320
Total Unusual Items Excluding Goodwill
-805.6780
-620.2390
275.8390
-86,164.8870
-3,991.7830
Total Unusual Items
-805.6780
-620.2390
275.8390
-86,164.8870
-3,991.7830
Normalized EBITDA
-9,247.9850
-6,232.4260
-5,438.9360
-10,274.0900
-8,757.4840
12/31/2020 - 7/2/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade